Serina Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Serina Therapeutics generated cash of -$7,800,000, which is less than the previous year. Cash used in financing activities reached the amount of $17,500,000 last year. Net change in cash is therefore -$300,000.
Cash Flow
| 2017 | -6.28M | 5K | 13.27M |
|---|---|---|---|
| 2019 | -10.16M | -361K | 6.26M |
| 2020 | -7.81M | -20K | 5.96M |
| 2021 | -2.25M | 823.32K | 1.07M |
| 2022 | -2.07M | 980.93K | 1.31M |
| 2023 | -7.8M | -10M | 17.5M |
SER Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 645K | 314.84K | 665.05K | 2.35M | 6.70M | 259K |
Operating activities | ||||||
Net income | -14.80M | -2.68M | -1.26M | -10.39M | -12.15M | -6.58M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 131K | 61.27K | 33.36K | 1.25M | 951K | 682K |
Stock-based compensation expense | 0 | 7.11K | 82.94K | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 7.11K | 82.94K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -607K | 1.10K | 1.00M | -30K | -232K | 322K |
Inventories | 0 | -164.41K | 218.35K | 0 | 0 | 0 |
Accounts payable | 0 | -2.13K | -367.28K | 382K | 169K | 267K |
Cash generated by operating activities | -7.8M | -2.07M | -2.25M | -7.81M | -10.16M | -6.28M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | -666K | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -9.68K | -108.43K | -20K | -641K | -1K |
Acquisitions Net | 0 | 0 | 466K | 0 | 0 | 0 |
Cash generated by investing activities | -10M | 980.93K | 823.32K | -20K | -361K | 5K |
Financing activities | ||||||
Common Stock Issued | 0 | 4.42K | 496K | 0 | 4.5M | 11.97M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 1.30M | -12.90K | -5.96M | 1.76M | 0 |
Cash used in financing activities | 17.5M | 1.31M | 1.07M | 5.96M | 6.26M | 13.27M |
Net Change In Cash | -300K | 217.38K | -350.20K | -1.82M | -4.35M | 7.11M |
Cash at end of period | 345K | 532.22K | 314.84K | 527K | 2.35M | 7.37M |